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ABSTRACT
Background: Although vitamin D insufﬁciency is
prevalent in the community, only a few population-
based studies have measured serum 25-hydroxy-
vitamin D (25OHD) levels during pregnancy and in
newborns. Maternal vitamin D deﬁciency has been
linked to pregnancy complications, as well as
hypocalcaemia and rickets in the newborn. Here, the
authors report third-trimester maternal and newborn-
serum 25OHD concentrations in 101 neonates whose
serum samples were sent for testing.
Methods: The newborn 25OHD levels were correlated
with the third-trimester maternal serum 25OHD levels
using a least-square regression analysis. All samples
were measured using an enzyme immunoassay (EIA).
Ten randomly selected newborn serum samples were
also measured using liquid chromatography/tandem
mass spectrometry LC-MSMS, and correlated with the
EIA method.
Results: Out of 99 mothers of the newborns, only 19,
42 and 68 had their 25OHD level measured in the ﬁrst,
second and third trimester respectively. The mean
maternal age was 30 years, while the mean maternal
third-trimester 25OHD concentration was 48 nmol/l. Of
the newborns, 53% were female, and 85% were term
deliveries. The mean newborn-serum 25OHD was
68 nmol/l. Neonatal 25OHD was related to maternal
third-trimester levels measured by EIA (r¼0.3;
newborn 25OHD¼0.42(maternal 25OHD)+44.2;
p¼0.02). EIA and LC-MSMS concentrations for
newborns correlated signiﬁcantly over a range
between 20 and 103 nmol/l by EIA (r¼0.9; EIA¼1.04
(LCMSMS)+10.1; p<0.00 (slope); p¼0.18 (intercept)).
The mean 25OHD concentration in women who
suffered pre-eclampsia and premature rupture of
membranes were 45 and 39 nmol/l respectively.
Conclusions: Newborn-serum 25OHD concentrations
depend on the maternal circulating plasma 25OHD
level at least during the third trimester. Neonatal
25OHD levels obtained by EIA correlated well with
LC-MSMS. Although the EIA values for neonates were
greater than LC-MSMS values, this difference was not
statistically signiﬁcant.
INTRODUCTION
Maternal vitamin D deﬁciency is a common
public-health problem.
1 2 Individuals with
deeply pigmented skin and those with
minimal skin exposure to sun are considered
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ARTICLE SUMMARY
Article focus
- There is evidence that maternal vitamin D status
affects fetal and neonatal development.
- Despite the evidence, testing for vitamin D during
pregnancy is not offered to many women in our
community.
- We hypothesise that the maternal vitamin D
status especially the 3rd trimester maternal
serum levels determines the neonatal vitamin D
status.
Key messages
- Despite National Guidelines, women in the third
trimester of pregnancy are vitamin D deﬁcient.
- Maternal vitamin D status determines the
neonatal vitamin D status.
- Women with very low levels of vitamin D may be
more likely to develop pregnancy and birth
comlications.
Strengths & limitations
Strengths
- Access to 100 newborn samples from a teaching
hospital.
- Validation of enzyme immunoassay with HPLCd
mass spectrometry for neonatal vitamin D.
Limitations
- Numbers of women with pregnancy and birth
complications are too small to make a strong
statement regarding direct effects of vitamin D.
- No follow-up data available for the neonates
(ie, developemental milestones etc).
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Open Access Researchto be particularly at risk of vitamin D deﬁciency.
3 During
intrauterine development, the fetus accumulates about
30 g of calcium from the maternal circulation, and
during lactation, a further 280e400 mg/day calcium is
secreted into the milk.
4 This results in an increased
demand for calcium in the mother, so it is important that
adequate vitamin D be available to ensure efﬁcient
intestinal absorption of calcium.
Vitamin D deﬁciency in pregnancy has been shown to
lead to signiﬁcant pregnancy complications. Maternal
complications include decreased weight gain,
5 hyper-
tension in pregnancy and pre-eclampsia.
1 In the
newborn, maternal vitamin D deﬁciency has been linked
to hypocalcaemia, low birth weight,
6 poor weight gain,
impaired development and rickets.
7 Although no health
beneﬁts have been associated with vitamin D supple-
mentation during pregnancy,
8 current evidence suggests
that deﬁciency may be an independent risk factor for
pregnancy and birth complications.
1
A recent revision of Perinatal Guidelines of South
Australia
9 recommends the measurement of serum
vitamin D in all at-risk women during their ﬁrst antenatal
visit. At-risk women are deﬁned as all women who
routinely wear head scarves, darker-skinned women,
newly arrived migrants and anyone who is housebound.
If the serum 25-hydroxy-vitamin D (25OHD) is
<60 nmol/l, the recommendation is to treat them with
1000 U of vitamin D per day. 25OHD measurements are
repeated at subsequent visits to monitor progress. The
rationale of this protocol is to prevent vitamin D deﬁ-
ciency in the newborn.
The following study was aimed at examining the rela-
tionship between concentrations of 25OHD in maternal
serum and newborn.
METHOD
This study was approved by the Royal Adelaide Hospital
Research Ethics Committee (protocol number 090901).
One hundred and one consecutive neonatal serum
samples were received from a tertiary hospital for 25OHD
analysis. Maternal data were obtained from the laboratory
database. Noenatal samples were from heel-prick capil-
lary blood samples collected for newborn screening tests
during a 3-month period (November, December and
January). These values were correlated with the mothers’
serum 25OHD measurements collected during the third-
trimester using regression analysis. There were two sets of
twins in the neonatal group, and there were 99 maternal
records. Any other maternal serum vitamin D concen-
trations which were measured during pregnancy were
also obtained from the database. The ﬁrst-trimester
measurement has been made in association with ante-
natal screening tests. However, a proportion of women
had a third-trimester 25OHD measurement requested by
their general practitioner, and this was either the ﬁrst
during the pregnancy or a follow-up to a previous
measurement in the ﬁrst or the second trimester. All
serum measurements were made using an enzyme
immunoassay (Immuno Diagnostic Systems, Scottsdale,
Arizona). Serum vitamin D was also measured in 10
randomly selected neonatal specimens using an LC/MS-
MS method (Applied Bio Systems) in order to verify the
immunoassay method for neonatal samples.
RESULTS
The ethnicity of the mother was recorded for 66 women.
Of these, 23 were Asian, 15 Middle Eastern, 12 Cauca-
sian, nine Indian and seven African. The mean maternal
age was 29.6 years. First-trimester weight was available for
31 mothers, and the mean weight was 64.6 kg (SD 10.8).
Eighty-ﬁve infants were delivered at term and 14 infants
preterm. Two deliveries were not dated. Spontaneous
vaginal delivery was recorded in 48 cases, instrumental
delivery in 22, elective caesarean sections in 12 and
emergency caesarean sections in 16; the mode of
delivery was unknown for 2. Maternal complications
recorded were premature rupture of membranes
(n¼10), pre-eclampsia (n¼7), postpartum haemorrhage
(n¼4), ante-partum haemorrhage (n¼3), oligohy-
dramnios (n¼1) and cholestasis (n¼1). Gestational
diabetes was reported in three women. Neonatal
complications recorded were breach presentation
(n¼5), shoulder dystocia (n¼4), small for gestational
age (n¼3), neonatal jaundice (n¼3) and congenital
laryngomalacia (n¼1).
For 99 mothers of the 101 neonates, serum 25OHD
was measured in the ﬁrst trimester, second trimester and
third trimester in 19, 42 and 68 women respectively.
Twenty-eight women had at least two measurements
during pregnancy. All 28 had a 25OHD level below the
recommended 60 nmol/l;
9 only 12 achieved a subse-
quent measurement above 60 nmol/l. The mean serum
25OHD in the ﬁrst, second and third trimesters
was 32 nmol/l, 33 nmol/l and 44 nmol/l respectively
(table 1). Table 2 shows the mean third-trimester serum
25OHD for the mothers and neonates. During the third
trimester, 78% of the women had a vitamin D level of
<60 nmol/l. The goal recommended by the Perinatal
Table 1 Maternal serum vitamin D concentrations and the
percentages with levels <25, 50 and 60 nmol/l for each
trimester
First
trimester
Second
trimester
Third
trimester
No 19 42 68
Mean (SD),
nmol/l
32 (15.6) 33 (17.6) 48 (20.1)
Median 30 30 46
Minemax 8e57 6e81 14e105
Percentage
<25 nmol/l
32 40 12
Percentage
<50 nmol/l
74 79 56
Percentage
<60 nmol/l
100 95 78
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9 is 60 nmol/l;
therefore 78% of the women were vitamin D deﬁcient or
insufﬁcient in the third trimester.
The mean 25OHD in the neonates was 68 nmol/l (17
to 177). Severe deﬁciency (<25 nmol/l) was detected in
4%, mild deﬁciency (<50 nmol/l) in 33% and normal
levels (>50 nmol/l)
10 in 63%.
The third-trimester maternal serum 25OHD and
neonatal 25OHD were correlated (r¼0.08; p¼0.02;
newborn 25OHD¼(0.4175maternal 25OHD)+44.234) as
shown in ﬁgure 1. No relationship was found between
neonatal 25OHD and maternal age.
Regression analysis of neonatal 25(OH)D measured
using enzyme immunoassay and LC/MS-MS showed
a good correlation between the methods (r¼0.9;
p<0.001; enzyme immunoassay¼1.04(LC/MS-MS)+10.1).
DISCUSSION
The women in our study were of mixed ethnic origin,
with a large proportion of migrants, many of whom have
dark skin and wear traditional dress, leading to lower
vitamin D production in the skin. These factors are well
recognised as risk factors for vitamin D deﬁciency.
However, the numbers in each group were too small for
a separate analysis.
Despite the perinatal guidelines for the diagnosis and
correction of vitamin D deﬁciency in pregnancy, only
19% of this group of mothers had their serum vitamin D
measured in the ﬁrst trimester. As many as 78% were
25OHD-deﬁcient during the 3rd-trimester. Only 68% of
the women had their vitamin D measured in the third
trimester. However, the average serum 25OHD for this
group of women gradually rose from the ﬁrst to the third
trimester, perhaps owing to supplementation. This
suggests that more than 78% of the women may have
been vitamin D deﬁcient during the ﬁrst trimester. All
third-trimester samples were collected in spring
(September to November), and a small seasonal inﬂuence
cannot be discounted. The rise in 25OHD with advancing
pregnancy may be a natural phenomenon similar to the
rise in steroid hormones. The mean serum 25OHD
during the third trimester was 48 nmol/l, which is
below the desirable limit of 60 nmol/l. Measurement of
vitamin D during the ﬁrst trimester may have been
beneﬁcial because this may have allowed the commence-
ment of supplementation earlier to enable serum levels to
normalise by third trimester. The incidence of pre-
eclampsia in this group was 7%, which is comparable with
the 5e7% incidence in all pregnancies.
11
A recent ﬁnding suggested that the factors associated
with maternal vitamin D deﬁciency were maternal
birthplace outside Australia, dark-skin prototype,
wearing a veil and younger maternal age.
12 Our cohort
consisted of a large proportion of immigrants from
multiple ethnic backgrounds, and this may have
contributed to the prevalence of vitamin D deﬁciency.
Neonatal serum 25OHD concentration was related to
third-trimester maternal vitamin D level. However, some
women may have been receiving supplementation closer
to delivery date, and thus may have had higher serum
levels without a rise in fetal stores. The relationship may
have been more signiﬁcant if vitamin D levels were
measured on the day of delivery.
2 A signiﬁcant
percentage of neonates were vitamin D deﬁcient at birth
(37%). This relates to the high prevalence of maternal
vitamin D deﬁciency.
12
There was a good correlation between the enzyme
immunoassay and LC-MS/MS for the measurement of
neonatal vitamin D, suggesting that immunoassay is
a valid method of neonatal vitamin D. In the samples
tested the enzyme immunoassay measured higher values
compared with the LC-MSMS method, but this differ-
ence was not statistically signiﬁcant. There is one report
in which neonates can have signiﬁcant concentrations of
the 3-epimer of 25OHD in serum, and this form of
25OHD may not be measured by different assays
13
leading to a variability between results obtained from
various assays.
Recognition of risk factors and early detection
of vitamin D deﬁciency, and supplementation with
vitamin D to achieve reasonable serum levels during
pregnancy, are important in order to prevent neonatal
vitamin D deﬁciency and related complications. Peri-
natal Practice Guidelines proposed by the government
do not appear to be used widely. This may also reﬂect on
the women not seeking general practitioner or obstetric
consultation during early pregnancy. Therefore, public-
Table 2 Mean serum 25OHD in mothers (third trimester)
and neonates
No
analysed
Mean
(nmol/l) SD
Uncomplicated 57 47 19.3
Pre-eclampsia 7 45 11.1
Premature rupture
of membranes
9 39 16.1
All neonates 101 68 41.1
Figure 1 Third trimester maternal 25(OH)D versus newborn
25(OH)D concentration. N¼68; r¼0.28.
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Third trimester 25OHD and newborn 25OHDeducation campaigns may be required through
community organisations and migrant resource centres.
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